Evidence map›Paper›PMID 36702776›Full record

ArticleGenetics2023

Hotspot of de novo telomere addition stabilizes linear amplicons in yeast grown in sulfate-limiting conditions.

Remington E Hoerr, Alex Eng, Celia Payen, Sara C Di Rienzi, M K Raghuraman, Maitreya J Dunham, Bonita J Brewer, Katherine L Friedman

Open access · bronzeAbstract read
In one paragraph

Article in Genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Telomeric amplicons ofbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. A comprehensive map of hotspots of de novo telomere addition inbioRxiv : the preprint server for biology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Remington E HoerrDepartment of Biological Sciences, Vanderbilt University, Nashville, TN 37235, USA.
Alex EngDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Celia PayenDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Sara C Di RienziDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
M K RaghuramanDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Maitreya J DunhamDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Bonita J BrewerDepartment of Genome Sciences, University of Washington, Seattle, WA 98195, USA.
Katherine L FriedmanDepartment of Biological Sciences, Vanderbilt University, Nashville, TN 37235, USA.
University of Washington · USVanderbilt University · US

Funding

Choreography of Eukaryotic DNA ReplicationR35GM122497 · NIGMS · UNIVERSITY OF WASHINGTON · PI BONITA J BREWER · 2017 to 2026
$5.7M
Cellular, Biochemical and Molecular Sciences Training ProgramT32GM137793 · NIGMS · VANDERBILT UNIVERSITY · PI Katherine Louise Friedman, TODD R GRAHAM · 2021 to 2026
$2.6M
Hotspots of de novo telomere addition as mediators of genomic instability in yeastR01GM123292 · NIGMS · VANDERBILT UNIVERSITY · PI FRIEDMAN, KATHERINE LOUISE · 2017 to 2020
$1.3M
Causes and consequences of gene copy number change in adapting yeast populationsR01GM094306 · NIGMS · UNIVERSITY OF WASHINGTON · PI DUNHAM, MAITREYA J · 2011 to 2015
$1.3M
NIGMS NIH HHS R01 GM094306NIGMS NIH HHS R01 GM123292NIGMS NIH HHS R35 GM122497NIGMS NIH HHS T32 GM137793NIH HHS R01GM123292
6 · The paper itself

Abstract

Evolution is driven by the accumulation of competing mutations that influence survival. A broad form of genetic variation is the amplification or deletion of DNA (≥50 bp) referred to as copy number variation (CNV). In humans, CNV may be inconsequential, contribute to minor phenotypic differences, or cause conditions such as birth defects, neurodevelopmental disorders, and cancers. To identify mechanisms that drive CNV, we monitored the experimental evolution of Saccharomyces cerevisiae populations grown under sulfate-limiting conditions. Cells with increased copy number of the gene SUL1, which encodes a primary sulfate transporter, exhibit a fitness advantage. Previously, we reported interstitial inverted triplications of SUL1 as the dominant rearrangement in a haploid population. Here, in a diploid population, we find instead that small linear fragments containing SUL1 form and are sustained over several generations. Many of the linear fragments are stabilized by de novo telomere addition within a telomere-like sequence near SUL1 (within the SNF5 gene). Using an assay that monitors telomerase action following an induced chromosome break, we show that this region acts as a hotspot of de novo telomere addition and that required sequences map to a region of <250 base pairs. Consistent with previous work showing that association of the telomere-binding protein Cdc13 with internal sequences stimulates telomerase recruitment, mutation of a four-nucleotide motif predicted to associate with Cdc13 abolishes de novo telomere addition. Our study suggests that internal telomere-like sequences that stimulate de novo telomere addition can contribute to adaptation by promoting genomic plasticity.

Indexed as

Saccharomyces cerevisiae ProteinsTelomeraseDNA Copy Number VariationsHumansSaccharomyces cerevisiaeSulfatesSulfate TransportersTelomereTelomere-Binding ProteinsCdc13 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsSUL1 protein, S cerevisiaeSulfatesSulfate TransportersTelomeraseTelomere-Binding ProteinsCdc13copy number variationde novo telomere additionDNA repairevolutionary genomicsgene amplificationSaccharomyces cerevisiae

Identifiers

PMID36702776
PMCPMC10213492
OpenAlexW4318184295

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.